Navkiran Kaur

Navkiran Kaur

Auto-generated profile, based on publicly available information

Navkiran Kaur


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
RSRashi Sehgal
Rashi Sehgal
NKNavkiran Kaur
Navkiran Kaur
RMRakhi Maiwall
Rakhi Maiwall
GRGayatri Ramakrishna
Gayatri Ramakrishna
JMJaswinder Singh Maras
Jaswinder Singh Maras
NTNirupma Trehanpati
Nirupma Trehanpati
Decompensated cirrhosis (DC) is susceptible to infections and sepsis. Neutrophils and monocytes provide the first line of defense to encounter infection. We aimed to evaluate proteins related to neutrophils functionality in sepsis. 70 (DC), 40 with sepsis, 30 without (w/o) sepsis and 15 healthy controls (HC) plasma was analyzed for proteomic analysis, cytokine bead array, endotoxin, cell free DNA and whole blood cells were analyzed for nCD64-mHLADR index, neutrophils-monocytes, functionality and QRT-PCR. nCD64-mHLADR index was significantly increased (p < 0.0001) with decreased HLA-DR expression on total monocytes in sepsis (p = 0.045). Phagocytic activity of both neutrophils and monocytes were significantly decreased in sepsis (p = 0.002 and p = 0.0003). Sepsis plasma stimulated healthy neutrophils, showed significant increase in NETs (neutrophil extracellular traps) and cell free DNA (p = 0.049 and p = 0.04) compared to w/o sepsis and HC. Proteomic analysis revealed upregulated- DNAJC13, TMSB4X, GPI, GSTP1, PNP, ANPEP, COTL1, GCA, APOA1 and PGAM1 while downregulated- AHSG, DEFA1,SERPINA3, MPO, MMRN1and PROS1 proteins (FC > 1.5; p < 0.05) associated to neutrophil activation and autophagy in sepsis. Proteins such as DNAJC13, GPI, GSTP1, PNP, ANPEP, COTL1, PGAM1, PROS1, MPO, SERPINA3 and MMRN1 showed positive correlation with neutrophils activity and number, oxidative burst activity and clinical parameters such as MELD, MELD Na and Bilirubin. Proteomic analysis revealed that faulty functionality of neutrophils may be due to the autophagy proteins i.e., DNAJC13, AHSG, TMSB4X, PROS1 and SERPINA3, which can be used as therapeutic targets in decompensated cirrhosis patients with sepsis.

1 July 2025 in Journal of Mid-life Health
Verified
Journal Article
Open access
PPPrachi Patel
Prachi Patel
SPShreedhanya Patil
Shreedhanya Patil
NKNavkiran Kaur
Navkiran Kaur
Estrogen is a key hormone that influences metabolism, health, and overall well-being throughout a woman’s life. Its levels fluctuate across different reproductive stages: perimenopause, menopause, and postmenopause – each bringing unique physiological changes. During perimenopause, estrogen helps regulate insulin production, glucose metabolism, and fat distribution. However, as levels become unstable in this phase, women may experience increased insulin resistance, shifts in fat storage, and a greater risk of metabolic disorders such as diabetes. Given its widespread effects, proactive lifestyle interventions are essential. A balanced diet rich in phytoestrogens, regular physical activity, and maintaining a healthy body weight can help manage hormonal shifts. Advancing research in molecular endocrinology and personalized medicine offers the potential for targeted strategies that deepen our understanding of estrogen’s tissue-specific effects. By personalizing interventions to individual hormonal transitions, we can improve women’s health outcomes and quality of life.

18 April 2024 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
MCMrinmoy Chakraborty
Mrinmoy Chakraborty
JKJasmine Kaur
Jasmine Kaur
GUGunjan
Gunjan
MKMeghavi Kathpalia
Meghavi Kathpalia
NKNavkiran Kaur
Navkiran Kaur

20 June 2024 in Breast Disease
Verified
Journal Article
Open access
PDF file
KSKeerti Singh
Keerti Singh
LALokita Agrawal
Lokita Agrawal
RGRhea Gupta
Rhea Gupta
DSDivyam Singh
Divyam Singh
MKMeghavi Kathpalia
Meghavi Kathpalia
NKNavkiran Kaur
Navkiran Kaur
Efficient treatment of cancer has been a subject of research by scientists for many years. Current treatments for cancer, such as radiotherapy, chemotherapy and surgery have been used in traditional combination therapy, but they have major setbacks like non-specificity, non-responsiveness in certain cancer types towards treatment, tumor recurrence, etc. Epidemiological data has shown that breast cancer accounts for 14% of cancer cases occurring in Indian women. In recent years, scientists have started to focus on the use of natural compounds like lectins obtained from various sources to counter the side effects of traditional therapy. Lectins like Sambucus nigra Agglutinin, Maackia amurensis lectin, Okra lectins, Haliclona caerulea lectin, Sclerotium rolfsii lectin, etc., have been discovered to have both diagnostic and therapeutic potential for breast cancer patients. Lectins have been found to have inhibitory effects on various cancer cell activities such as neo-angiogenesis, causing cell cycle arrest at the G1 phase, and inducing apoptosis. The major idea behind the use of lectins in cancer diagnostics and therapeutics is their capability to bind to glycosylated proteins that are expressed on the cell surface. This review focuses on an exploration of the roles of post-translational modification in cancer cells, especially glycosylation, and the potential of lectins in cancer diagnosis and therapeutics.

6 April 2023 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MKMeghavi Kathpalia
Meghavi Kathpalia
ASAnurag Sharma
Anurag Sharma
NKNavkiran Kaur
Navkiran Kaur
Background: Chemotherapy, the only treatment option for metastatic triple-negative breast cancer (mTNBC), showed decreased survival rates. Trophoblast cell surface antigen-2 (Trop-2) could be a possible target for antibody-drug conjugates (ADCs). Objective: Sacituzumab govitecan (SG), an anti-Trop-2 ADC for pretreating relapsed/refractory mTNBC patients, was studied to know the efficacy and safety profile of the drug in mTNBC. Methods: The present review searched MEDLINE (via PubMed), WHO Clinical Trial Registry, Clinical Trials.gov, and Cochrane Central Register of Controlled Trials until December 25, 2022. The studies searched comprised randomized trials and observational studies (retrospective [case-control, cross-sectional] and prospective [cohort designs]). Efficacy assessment was performed in terms of complete response (CR), partial response (PR), objective response rate (ORR), stable disease (SD), progressive disease (PD), and clinical benefit rate (CBR), and safety in terms of adverse events. Results: The overall random-effects pooled prevalence of CR was 4.9 (95% CI: 3.2-7.1), PR was 35.6 (95% CI: 31.5-39.9), ORR was 6.8 (95% CI: 5.9-7.8), SD was 8.0 (95% CI: 6.7-9.4), PD was 5.1 (95% CI: 4.1-6.3), and CBR was 13.4 (95% CI: 11.8-15.1). Adverse events associated with the drug were neutropenia, fatigue, anemia, nausea, and others. Conclusion and Relevance: This is the first meta-analysis conducted in relapsed/refractory mTNBC patients and found that SG is efficacious but associated with some adverse effects that are related to exposure to the drug. The application of these results will allow clinicians to use SG in the management of patients with mTNBC.

21 April 2016 in BJR|case reports
Verified
Journal Article
Open access
RKRashmeet Kaur
Rashmeet Kaur
SGSimmi Garg
Simmi Garg
NKNavkiran Kaur
Navkiran Kaur
PSParamdeep Singh
Paramdeep Singh
Disseminated hydatidosis is a rare disease and may involve any organ of the human body. In this case, an elderly female got infected by Echinococcus and presented with disseminated disease. A fistulous communication developed between one of the hydatid cysts present in the retrovesical region and the bladder, because of which the patient presented with hydatiduria.